Other Species / Isoforms
  LRWD1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S17-p
MQRGRPKsDRLGKIR
Upstream
0 2
Regulatory protein:
  • OGT (human)
LRWD1 (human) MQRGRPKsDRLGKIR S17-p
LRWD1 (mouse) LQRGRPKTDKLGKIQ T17
LRWD1 (rat) LQRGRPKTDRLGKIQ T17
S25-p
DRLGKIRsLDLSGLE
0 1
LRWD1 (human) DRLGKIRsLDLSGLE S25-p
LRWD1 (mouse) DKLGKIQSLNLSGLQ S25
LRWD1 (rat) DRLGKIQSLNLSGLE S25
K41-ub
LSEHLDPkLLCRLTQ
0 2
LRWD1 (human) LSEHLDPkLLCRLTQ K41-ub
LRWD1 (mouse) LSEHLDPNLLGRLKK N41
LRWD1 (rat) LSEHLDPNLLGRLKK N41
K125-ub
TLRKVNGkDASSTYS
0 1
LRWD1 (human) TLRKVNGkDASSTYS K125-ub
LRWD1 (mouse) KLRKVNGKDTASTCS K125
LRWD1 (rat) KLRKVNGKDTASTCS K125
K151-ub
RVTAHWEkFMATLGP
0 1
LRWD1 (human) RVTAHWEkFMATLGP K151-ub
LRWD1 (mouse) RVTAHWQKFIATVSP K151
LRWD1 (rat) QVTALWQKFIATVNP K140
K171-ub
KAQADFVkSAVRDVR
0 4
LRWD1 (human) KAQADFVkSAVRDVR K171-ub
LRWD1 (mouse) KVRADFMRSAVRDVC R171
LRWD1 (rat) KVQADFMRSAVRDVR R160
S196-p
QWRVRMIsEELVAAS
0 2
LRWD1 (human) QWRVRMIsEELVAAS S196-p
LRWD1 (mouse) QWRVRMIAEELVASG A196
LRWD1 (rat) QWRVRMIAEELVASG A185
S212-p
TQVQKANsPEKPPEA
Upstream
0 35
Treatment
  • dasatinib
  • LRRK2-IN-1
LRWD1 (human) TQVQKANsPEKPPEA S212-p
LRWD1 (mouse) AQVQDAKVPVEHPQA V212
LRWD1 (rat) AQAHEANASVEHPQA A201
K224-ub
PEAGAAHkPRARLAA
0 1
LRWD1 (human) PEAGAAHkPRARLAA K224-ub
LRWD1 (mouse) PQAAGASKFRAREVA K224
LRWD1 (rat) PQAAVGSKLRARKVT K213
K233
RARLAALKRPDDVPL
0 1
LRWD1 (human) RARLAALKRPDDVPL K233
LRWD1 (mouse) RAREVASkRPGKDPV K233-ac
LRWD1 (rat) LRARKVTKRPDDDEI K221
S241-p
RPDDVPLsLsPskRA
0 11
LRWD1 (human) RPDDVPLsLsPskRA S241-p
LRWD1 (mouse) RPGKDPVTLPPSKRV T241
LRWD1 (rat) RPDDDEISLPPTKRV S229
S243-p
DDVPLsLsPskRACA
Upstream
0 36
Regulatory protein:
  • OGT (human)
Treatment
  • metastatic potential
  • nocodazole
LRWD1 (human) DDVPLsLsPskRACA S243-p
LRWD1 (mouse) GKDPVTLPPSKRVRA P243
LRWD1 (rat) DDDEISLPPTKRVRA P231
S245-p
VPLsLsPskRACAsP
Upstream
0 11
Treatment
  • EGF
  • nocodazole
LRWD1 (human) VPLsLsPskRACAsP S245-p
LRWD1 (mouse) DPVTLPPSKRVRALP S245
LRWD1 (rat) DEISLPPTKRVRAsP T233
K246-ub
PLsLsPskRACAsPs
0 2
LRWD1 (human) PLsLsPskRACAsPs K246-ub
LRWD1 (mouse) PVTLPPSKRVRALPP K246
LRWD1 (rat) EISLPPTKRVRAsPP K234
S251-p
PskRACAsPsAQVEG
Upstream
0 31
Regulatory protein:
  • PRP4 (human)
Treatment
  • EGF
LRWD1 (human) PskRACAsPsAQVEG S251-p
LRWD1 (mouse) PSKRVRALPPAQAEG L251
LRWD1 (rat) PTKRVRAsPPAQTED S239-p
S253-p
kRACAsPsAQVEGsP
0 8
LRWD1 (human) kRACAsPsAQVEGsP S253-p
LRWD1 (mouse) KRVRALPPAQAEGsP P253
LRWD1 (rat) KRVRAsPPAQTEDSP P241
S259-p
PsAQVEGsPVAGsDG
Upstream
0 33
Regulatory protein:
  • PRP4 (human)
Treatment
  • EGF
LRWD1 (human) PsAQVEGsPVAGsDG S259-p
LRWD1 (mouse) PPAQAEGsPMGADGG S259-p
LRWD1 (rat) PPAQTEDSPMDAAGG S247
S264-p
EGsPVAGsDGsQPAV
0 2
LRWD1 (human) EGsPVAGsDGsQPAV S264-p
LRWD1 (mouse) AEGsPMGADGGQAAL A263
LRWD1 (rat) TEDSPMDAAGGQAAL A251
S267-p
PVAGsDGsQPAVKLE
0 1
LRWD1 (human) PVAGsDGsQPAVKLE S267-p
LRWD1 (mouse) sPMGADGGQAALHLE G266
LRWD1 (rat) SPMDAAGGQAALHLE G254
T328-p
VCVIDCQtGIVLHKy
0 1
LRWD1 (human) VCVIDCQtGIVLHKy T328-p
LRWD1 (mouse) VCVIDCQTGLVLHKY T330
LRWD1 (rat) VCVIDCQTGLVLHKY T318
Y335-p
tGIVLHKyKAPGEEF
0 1
LRWD1 (human) tGIVLHKyKAPGEEF Y335-p
LRWD1 (mouse) TGLVLHKYKVPGEEF Y337
LRWD1 (rat) TGLVLHKYKVPGEEF Y325